Literature DB >> 30332287

Incomplete Thyroid Ultrasound Reports for Patients With Thyroid Nodules: Implications Regarding Risk Assessment and Management.

Manolhas Karkada1, Andreu F Costa2, Syed Ali Imran3, Robert D Hart4, Martin Bullock5, Gabriela Ilie6,7,8, Murali Rajaraman8.   

Abstract

OBJECTIVE: The purpose of this study was to determine the completeness of thyroid ultrasound (US) reports, assess for differences in report interpretation by clinicians, and evaluate for implications in patient care.
MATERIALS AND METHODS: We retrospectively reviewed thyroid US examinations performed between January and June 2013 in Nova Scotia, Canada. Baseline examinations that identified a nodule were evaluated for 10 reporting elements. Reports that lacked a comment regarding malignancy risk or a recommendation for biopsy were considered unclassified and were graded by three clinical specialists in accordance with the 2015 American Thyroid Association management guidelines. Interrater agreement was assessed using the Cohen kappa statistic. A radiologist reviewed the images of unclassified nodules, and on the basis of radiologic grading, biopsy rates and pathologic findings were compared between nodules that did and did not warrant biopsy.
RESULTS: Of 971 first-time thyroid US studies, 478 detected a nodule. The number of reports lacking a comment on the 10 elements ranged from 154 to 433 (32-91%). A total of 222 nodules (46%) were unclassified, and agreement in assigned grading by the clinical specialists was very poor (κ = 0.07; p < 0.05). According to radiologist grading, only 57 of 127 biopsies were performed on nodules that warranted biopsy, and 16 of 95 biopsies were performed unnecessarily. On the basis of the three clinical specialists' interpretation, 10, 31, and 33 reports were considered too incomplete to assign a grade; 40, 10, and four biopsies would have been unnecessarily ordered; and zero, three, and four cancers would have been missed.
CONCLUSION: There is widespread underreporting of established elements in thyroid US reports, and this causes confusion and discrepancy among clinical specialists regarding the risk of malignancy and the need for biopsy.

Entities:  

Keywords:  American Thyroid Association guidelines; radiology report; thyroid carcinoma; ultrasound

Mesh:

Year:  2018        PMID: 30332287     DOI: 10.2214/AJR.18.20056

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  6 in total

1.  Thyroid Ultrasound Reports: Deficiencies and Recommendations.

Authors:  Laila Qadan; Adel Ahmed; Kusum Kapila
Journal:  Med Princ Pract       Date:  2019-02-10       Impact factor: 1.927

2.  Thyroid Ultrasound Reports: Will the Thyroid Imaging, Reporting, and Data System Improve Natural Language Processing Capture of Critical Thyroid Nodule Features?

Authors:  Kallie J Chen; Priya H Dedhia; Joseph R Imbus; David F Schneider
Journal:  J Surg Res       Date:  2020-08-13       Impact factor: 2.192

3.  Integrity of clinical information in radiology reports documenting pulmonary nodules.

Authors:  Ronilda Lacson; Laila Cochon; Patrick R Ching; Eseosa Odigie; Neena Kapoor; Staci Gagne; Mark M Hammer; Ramin Khorasani
Journal:  J Am Med Inform Assoc       Date:  2021-01-15       Impact factor: 4.497

4.  ACR TI-RADS Recommendations: A Call to Contextualize Radiologists' Recommendations for Thyroid Nodules With the Clinical Scenario.

Authors:  Naykky Singh Ospina; Natalia Genere; Jenny K Hoang; Juan P Brito
Journal:  J Am Coll Radiol       Date:  2021-05-24       Impact factor: 6.240

5.  Different sonographic features of peripheral thyroid nodule calcification and risk of malignancy: a prospective observational study.

Authors:  Mehrdad Nabahati; Naser Ghaemian; Zoleika Moazezi; Rahele Mehraeen
Journal:  Pol J Radiol       Date:  2021-06-18

6.  Ultrasonographic characteristics of thyroid metastasis from clear cell renal cell carcinoma: A case report.

Authors:  Peng Tian; Wenyan Du; Xiaoxi Liu; Wenzhe Xu; Xiaoyue Rong; Zekai Zhang; Yanzhen Wang
Journal:  Medicine (Baltimore)       Date:  2020-11-06       Impact factor: 1.817

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.